Genes and childhood leukemia

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• Leukemia is a diverse blood cancer originating from hematopoietic stem cells, common in children.
• It involves uncontrolled cell proliferation and blocked differentiation due to genetic mutations.
• Leukemogenesis is driven by cytogenetic and molecular alterations impacting key cellular pathways.

Purpose of the Study:

• To explore the genetic underpinnings of leukemia.
• To connect genetic changes to disease pathobiology.
• To highlight the diagnostic, prognostic, and therapeutic implications of understanding leukemia genetics.

Main Methods:

• Analysis of genetic mutations and rearrangements in leukemia.
• Investigation of specific genetic lesions in T-lineage acute lymphoblastic leukemia (T-ALL), B-lineage acute lymphoblastic leukemia (B-ALL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML).

Main Results:

• Identified mutations affect signal transduction, hematopoiesis, oncogenes, tumor suppressors, and apoptosis regulators.
• Specific examples include TCR translocations in T-ALL, transcription factor mutations in B-ALL, gene disruptions in AML, and BCR-ABL1 fusion in CML.
• These genetic alterations significantly impair normal cell function.

Conclusions:

• Deepening the understanding of leukemia's genetic landscape enhances knowledge of its pathobiology.
• Genomic event investigation is crucial for precise patient stratification.
• This knowledge supports personalized medicine, reduces treatment toxicity, and enables targeted therapy development.